InSilico Medicine Cayman TopCo (FRA:O15)

Market Cap	2.90B
Revenue (ttm)	47.90M -34.5%
Net Income	-300.07M
EPS	-3.82
Shares Out	n/a
PE Ratio	n/a
Forward PE	150.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	5.10
Previous Close	5.05
Day's Range	5.10 - 5.30
52-Week Range	3.58 - 9.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About FRA:O15

InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The company is also involved in research and development collaboration, softwar...

• Industry: Prepackaged Software
• Founded: 2014
• Employees: 317
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: O15

Financial Performance

In 2025, FRA:O15's revenue was $56.24 million, a decrease of -34.48% compared to the previous year's $85.83 million. Losses were -$352.32 million, 1960.8% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error